AU4709399A - Phospholipid vesicle-tissue factor complex preparations and methods of making and using same - Google Patents

Phospholipid vesicle-tissue factor complex preparations and methods of making and using same

Info

Publication number
AU4709399A
AU4709399A AU47093/99A AU4709399A AU4709399A AU 4709399 A AU4709399 A AU 4709399A AU 47093/99 A AU47093/99 A AU 47093/99A AU 4709399 A AU4709399 A AU 4709399A AU 4709399 A AU4709399 A AU 4709399A
Authority
AU
Australia
Prior art keywords
making
methods
same
tissue factor
factor complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47093/99A
Inventor
Victor J. Marder
Hans-Peter Doz. Schwarz
Juergen Siekmann
Peter L. Turecek
Katalin Varadi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4709399A publication Critical patent/AU4709399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7454—Tissue factor (tissue thromboplastin, Factor III)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7456—Factor V
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU47093/99A 1998-06-23 1999-06-23 Phospholipid vesicle-tissue factor complex preparations and methods of making and using same Abandoned AU4709399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9041798P 1998-06-23 1998-06-23
US60090417 1998-06-23
PCT/US1999/014183 WO1999066939A1 (en) 1998-06-23 1999-06-23 Phospholipid vesicle-tissue factor complex preparations and methods of making and using same

Publications (1)

Publication Number Publication Date
AU4709399A true AU4709399A (en) 2000-01-10

Family

ID=22222689

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47093/99A Abandoned AU4709399A (en) 1998-06-23 1999-06-23 Phospholipid vesicle-tissue factor complex preparations and methods of making and using same

Country Status (2)

Country Link
AU (1) AU4709399A (en)
WO (1) WO1999066939A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501650A1 (en) * 2005-02-22 2006-10-15 Technoclone Ges M B H PROCESS FOR DETERMINING COOLING ACTIVATION AND APPARATUS FOR CARRYING OUT SAID METHOD

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
EP0656424B1 (en) * 1993-12-03 2002-02-06 Baxter Aktiengesellschaft Assay to determine the sensitivity to activated protein C
DE4416180C2 (en) * 1994-05-06 1997-08-14 Immuno Ag Stable preparation for the treatment of blood coagulation disorders and method for producing this preparation
DE4416166C2 (en) * 1994-05-06 1997-11-20 Immuno Ag Stable preparation for the treatment of blood clotting disorders

Also Published As

Publication number Publication date
WO1999066939A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
AU6079598A (en) Additive preparation and method of use thereof
AU6691698A (en) Hollow medical wires and methods of constructing same
EP0863748A4 (en) Liposomal compositions and methods of using them
AU4990397A (en) Compound-loaded liposomes and methods for their preparation
AU6886598A (en) Hosel construction and method of making the same
AU8298598A (en) Supported graft and methods of making same
AU5382499A (en) Self-evolving database and method of using same
AU7710198A (en) Single pass lead and method of use
AU4557796A (en) Low density ready-to-spread frosting and method of preparation
AU4907897A (en) Therapeutic liposome composition and method
AU5699799A (en) Makeup compositions and methods of making same
AU6142698A (en) Easy open package and method of making same
AU3477297A (en) Changeable graphics and methods of making and using same
AU3068699A (en) Skin equivalent and methods of forming and using same
AU1532297A (en) Starch-emulsifier composition and methods of making
AU2460099A (en) Mesoporous materials and methods of making the same
AU6577898A (en) Structural element and method of making
AU5733098A (en) Inlaid portfolio and method of making
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU7822998A (en) Electrical component assemblies and methods of making same
AU6270799A (en) Firestarter and method of making same
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU2165497A (en) Insecticidal composition and method of preparation
AU4156897A (en) Achievement plaque and method of making same
AU1907100A (en) Omeprazole solution and method of using same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase